DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
King R, Tiede C, Simmons K, Fishwick C, Tomlinson D, Ajjan R.
Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes.
Lancet 2015;
385 (Suppl. 01) S57
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.